All About: Schizophrenia
[Note: If you have schizophrenia/are schizophrenic (not sure if the community prefers person-first or identity-first language, so I’m giving y’all both), please feel free to chime in with corrections or additions in the comments. I don’t know what I don’t know, but I’m always willing to learn.]
Pathology = Study of Disease
Pathology addresses the following components of disease:
cause/etiology
mechanisms of development (pathogenesis)
structural alterations of cells, tissues, and organs
functional alterations of cells, tissues, and organs (pathophysiology)
the consequences of those changes (clinical symptoms)
Characteristics
The most typical feature of schizophrenia is psychosis:
severe distortions of reality and perception
disturbances in intellectual function, affect, motivation, social relationships, and motor behavior
relapsing episodes
- This can be so incapacitating that voluntary or involuntary hospitalization is required.
Classification of Mental Disorders in the DSM-5
Psychiatric disorders are listed in the DSM = Diagnostic and Statistical Manual of Mental Disorders.
- published by the American Psychiatric Association (APA)
- currently on 5th edition (2013)
1.2 Section II: diagnostic criteria and codes
- 1.2.1 Neurodevelopmental disorders
- 1.2.2 Schizophrenia spectrum and other psychotic disorders
- 1.2.3 Bipolar and related disorders
- 1.2.4 Depressive disorders
- 1.2.5 Anxiety disorders
- 1.2.6 Obsessive-compulsive and related disorders
- 1.2.7 Trauma- and stressor-related disorders
- 1.2.8 Dissociative disorders
- 1.2.9 Somatic symptom and related disorders
- 1.2.10 Feeding & eating disorders
- 1.2.11 Sleep-wake disorders
- 1.2.12 Sexual dysfunctions
- 1.2.13 Gender dysphoria
- 1.2.14 Disruptive, impulse-control, and conduct disorders
- 1.2.15 Substance-related and addictive disorders
- 1.2.16 Neurocognitive disorders
- 1.2.17 Paraphilic disorders
- 1.2.18 Personality disorders
Diagnosis
Criterion A: Characteristic Symptoms
- Two or more of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated). At least one of these should include symptoms 1-3 (positive symptoms).
Delusions
Hallucinations
Disorganized speech
Disorganized or catatonic behavior
Negative symptoms (e.g. blunted emotions)
Cognitive deficits
Criterion B: Social/Occupational Dysfunction
Criterion C: Duration of Six Months or More
Criterion D: Schizoaffective and Mood Disorder Exclusion
Criterion E: Substance/General Mood Condition Exclusion
Criterion F: Relationship to Global Development Delay or Autism Spectrum Disorder
[Note: If you’ve been misdiagnosed with schizophrenia when you were actually dealing with schizoaffective disorder, autism, substance use, a mood disorder, etc., please feel free to share your experience in the comments.]
Delusion: a belief that is held with strong conviction, despite superior evidence to the contrary.
- Karl Jaspers (1913) established three main criteria for a belief to be considered delusional:
certainty (held with absolute conviction)
incorrigibility (not changeable by compelling counter-argument or proof to the contrary)
impossibility or falsity of content (implausible, bizarre, or patently untrue)
- Examples:
Delusion of persecution involving the individual’s belief that others are spying on or planning to harm them
Delusions that thoughts are imposed from an outside source, such as outer space
Hallucinations: pathological forms of perception.
- Auditory hallucinations are frequent and are usually voices that are insulting or commanding.
- Visual hallucinations are rarer (in catatonic schizophrenia). More typical with epilepsy or hallucinogen use.
- Gustatory, olfactory, and somatic sensations also occur [note: I don’t have stats on the frequency of these; please share them if you got ‘em.]
Disorganized Speech
- sometimes called “word salad”
- frequent change of conversation topics with no connection between sentences
- speech can follow grammatical rules, but content makes little sense
Disorganized or Catatonic Behavior
- Motor activity is reduced and characterized by inappropriate and bizarre postures, rigidity, or “purposeless” and stereotyped movements (e.g. rocking or pacing).
- At times, people with schizophrenia (particularly the paranoid type) can become agitated and/or violent.
Catatonia: motor immobility and behavioral abnormality manifested by stupor.
- Stupor = lack of critical cognitive function and a level of consciousness wherein the person is almost entirely unresponsive and only responds to base stimuli such as pain.
Negative Symptoms
Blunted emotions = emotions may be absent or totally inappropriate to the situation. Sudden and unpredictable changes of emotion are also common.
Inability to experience pleasure
Social withdrawal
Lack of eye contact
Lack of motivation
Poverty of speech
Cognitive Deficits
Schizophrenia is classified as a thought disorder, characterized by illogical thinking, lack of reasoning, and inability to recognize reality.
Cognitive symptoms include impaired working memory, executive functioning, and attention. Many cognitive deficits impair the ability to function at school, at work, etc.
Onset of Schizophrenia
- Symptoms most often begin during the late teenage years and early twenties, but there are gender differences. After age 36, more women than men experience their first episode.
Etiology of Schizophrenia
- Although schizophrenia was described as early as 1000 BC, its causes remain unknown.
- It is increasingly regarded as a neurodevelopmental disorder with a strong genetic component.
Importance of genetics is shown by many family, twin, and adoption studies.
Other factors must be involved as well; we’re still figuring those out.
Lifetime risks of developing schizophrenia among relatives of an affected individual
Events during perinatal brain development can contribute to the occurrence of schizophrenia.
- These complications include:
brain injury during pregnancy or delivery caused by oxygen deprivation
drug use
exposure to viral infection (ex. measles) in the 2nd trimester
endocrine disorders
severe malnutrition
- During adolescence, a period of significant brain development, excessive synaptic pruning can result in loss of cortical gray matter.
- Cannabis use during adolescence might increase the risk.
Neurobiology of Schizophrenia: Structural Changes
- Recent advances in technology have revealed abnormalities of brain structure and function in individuals with schizophrenia.
- Many studies show cerebral atrophy and enlargement of fluid-filled ventricles following cell loss.
Brain Imaging & Mental Disorders
- Brain imaging techniques are currently not used to diagnose mental disorders.
- Imaging is currently used for research purposes and is helping to identify the brain regions involved in different pathologies.
- Numerous studies show that hippocampal cells of patients with schizophrenia are more disorganized than those of healthy subjects.
Neurobiology of Schizophrenia: Functional Changes
- Brain functional changes include reduced function of the prefrontal cortex (PFC), called hypofrontality.
- Reduced blood flow is associated with less glucose use, which indicates how active the brain cells are.
- Imaging studies show less blood flow to the frontal cortex when people with schizophrenia are performing cognitive tasks, such as the Wisconsin Card Sorting Test (WCST).
Neurobiology of Auditory Hallucinations
- Reduced gray matter volume in the temporal lobe
- Impaired processing in a prefrontal and temporal lobe neuronal network, due to hyper-activation of temporal lobe regions, including the auditory cortex, which is not inhibited due to impairment of prefrontal executive inhibitory functions.
Neurobiology of Schizophrenia: Functional Changes
- Eye-movement dysfunctions such as inability to visually track an object.
- Failure to track is also common in relatives of schizophrenic patients. The defective eye-tracking gene may be inherited along with the genes for schizophrenia.
The dopamine hypothesis = excess DA function results in positive symptoms of schizophrenia.
- It was suggested by the fact that amphetamine (which increases dopamine) can produce a psychotic reaction in healthy individuals, which can be reversed by DA antagonists.
- There is a strong correlation between D2 receptor blockade and reduction of schizophrenic symptoms.
DA imbalance hypothesis:
reduced DA function in mesocortical neurons (negative symptoms and impaired thinking) = D1 receptors
excess DA function in mesolimbic neurons (positive symptoms) = D2 receptors
Hypoglutamate hypothesis:
- Blocking NMDA receptors with PCP or ketamine produces schizophrenia-like symptoms in healthy individuals and exacerbates symptoms in schizophrenic patients.
- PCP and ketamine produce both the positive and negative symptoms.
- Antipsychotic drug clozapine interacts with the glutamate receptor and increases glutamate levels in the PFC of rats.
Schizophrenia: Treatments
- Before drug therapy, patients were confined to mental hospitals where treatment was limited to isolation or restraint, “shock” therapy using insulin-induced seizures or electrical currents, and surgery such as prefrontal lobotomy.
Lobotomy: consists of cutting the connections to and from the prefrontal cortex.
- controversial procedure accompanied by frequent and serious side effects
- was used to treat psychiatric (and occasionally other) conditions from 1935 till mid-1950s [note: gay men and lesbians were subjected to lobotomies in an attempt to “cure” them during this time period.]
- The dramatic decrease in the number of resident patients in state and municipal mental hospitals in the United States began after 1955, when psychoactive drugs were introduced into widespread therapeutic use.
Anti-psychotic Drugs
Neuroleptics = older term for anti-psychotic drugs
- Typical anti-psychotics: have motor side effects (ex. Chlorpromazine, Haloperidol)
- Atypical anti-psychotics (2nd generation): fewer side effects (ex. Clozapine, Risperidone)
- Effectiveness of these drugs has been demonstrated hundreds of times, especially for positive symptoms.
- Negative and cognitive symptoms are more resistant to treatment.
- The law of thirds = 1/3 of patients respond well to treatment, 1/3 shows significant improvements but is vulnerable to relapse, and 1/3 fails to respond.
After initial recovery, anti-psychotic drugs are prescribed as maintenance therapy to prevent relapse.
- Unpleasant side effects cause many patients to stop treatment.
- Psychotherapy and group therapy are important additions to drug therapy.
Anti-psychotic drugs block D2 receptors.
- A strong correlation exists between ability of a drug to displace a radio-labeled ligand on DA receptors and average clinical daily dose required.
- D2 receptors are located in the basal ganglia, nucleus accumbens, amygdala, hippocampus, and less in the cerebral cortex.
PET images show replacement of radio-labels on striatal D2 receptors by different anti-psychotic drugs.
The drugs also bind to other receptors, but there is no clear relationship between clinical effectiveness and binding to serotonin, adrenergic, histamine, or D1 receptors.
Anti-psychotics: Side Effects
Side effects depend on which receptor the drug binds to.
- Dopamine pathways in the brain are important for understanding drug action:
Nigrostriatal pathway (Substantia nigra ---> Striatum): Motor side effects
Hypothalamus ---> Pituitary gland pathway (regulates pituitary hormone secretion): Hormonal side effects
Parkinsonism: motor side effects that resemble symptoms of Parkinson’s disease:
tremors
akinesia (slowing or loss of voluntary movement)
muscle rigidity
restlessness (inability to sit still)
loss of facial expressions
- Parkinson’s is caused by loss of cell bodies in the substantia nigra, which gives rise to the nigrostriatal pathway.
- Lack of DA function in the striatum causes the motor effects.
Tardive dyskinesia (TD) is characterized by stereotyped involuntary movements, particularly of the face and jaw, quick and uncontrolled movements of the arms and legs, and other motor effects.
- Incidence of TD increases with duration of treatment.
Woman with tardive dyskinesia (TD)
- Neuroendocrine effects:
decreased sex drive
no menstruation
increased prolactin release
inhibition of growth hormone release
- Metabolic effects (typically significant weight gain)
- Inability to regulate body temperature
Neuroleptic malignant syndrome (NMS) is serious and life-threatening.
- characterized by fever, rigidity, altered consciousness, and autonomic nervous system inability (including rapid heart rate and fluctuations in blood pressure)
- Rapid diagnosis and immediate action have significantly reduced mortality risk.
Other side effects of anti-psychotics:
Blocking cholinergic synapses produces dry mouth, blurred vision, difficulty in urination, GI problems
Anti-adrenergic action leads to dizziness or blacking out
Many drugs also cause sedation
Anti-psychotics: Dependence
Anti-psychotic drugs causes little or no tolerance, physical dependence, or abuse potential, and have high therapeutic index.
- Lack of abstinence syndrome may be due to long half-life:
Haloperidol (20 hours)
Olanzapine (30 hours)
Aripiprazole (75 hours)
Atypical Anti-psychotics
“Atypical” or “second-generation” drugs reduce positive symptoms of schizophrenia as well as classical drugs, but without significant motor side effects.
- Some new drugs do not produce TD or increase prolactin secretion.
- Three types:
Selective D2 receptor antagonists
Dopamine system stabilizers
Broad-spectrum anti-psychotics
Dopamine system stabilizers:
Partial DA agonists compete with DA for receptors and reduce DA effect (ex. aripiprazole, trade name: Abilify)
Has few side effects
Little evidence of cardio-toxicity, weight gain, or motor side effects
Adverse effects such as headache, agitation, insomnia, and nervousness are minor.
Broad-spectrum anti-psychotics block other receptor types in addition of D2 receptors (ex. Clozapine, risperidone)
- Clozapine has weak affinities for D1 and D2 and strong affinities for serotonergic, muscarinic, histaminergic, and D4 receptors.
- It is more effective for patients who do not respond to total anti-psychotics.
- Clozapine has fewer motor side effects. However, it does have many other side effects because of its action on multiple receptors, including:
weight gain
sedation
agranulocytosis (a rare blood disorder that severely reduces number of white blood cells)
cardiac toxicity
- Clinical trials in the UK found that clozapine was superior to the other anti-psychotics in the treatment of negative symptoms.
- Clozapine can improve cognitive symptoms.
appears to be the only true “atypical” anti-psychotic, because no other 1st or 2nd generation anti-psychotics have this positive effect
The Search for a New Drug: Possible Approaches
(1) Enhance Acetylcholine: Clozapine is the only drug currently in use that enhances cognition. It does this by increasing acetylcholine release in the hippocampus.
(2) Selectively enhance D1 receptor signaling in PFC with D1 agonists.
Hypofrontality is associated with reduced DA function in PFC, especially at D1 receptors.
(3) Enhancing glutamate activity at NMDA receptors might reverse negative and cognitive symptoms.
Blocking NMDA receptors by ketamine can induce psychosis, cognitive deficit. So maybe stimulating NMDA receptors can have the opposite effect.
7 notes
·
View notes